Logotype for Georgia Capital PLC

Georgia Capital (CGEO) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Georgia Capital PLC

Q4 2024 earnings summary

23 Dec, 2025

Executive summary

  • NAV per share rose 15% quarter-on-quarter in 4Q24 to GEL 95.95, up 15.7% year-over-year, driven by strong portfolio performance and significant share buybacks.

  • Operating cash flow and EBITDA grew sharply, with EBITDA up 53.3% in 4Q24 and 25% for the year; free cash flow reached $48 million in 2024.

  • Major divestment of 80% equity in beer and distribution businesses completed, generating c.US$63 million in cash proceeds and boosting liquidity.

  • Share buybacks accelerated, with over 12 million shares repurchased since demerger, reducing share count by 25.3%.

  • NCC ratio improved by 3.1 percentage points to 12.8% at year-end, reflecting lower leverage and enhanced portfolio value.

Financial highlights

  • Portfolio value up 8.5% quarter-on-quarter to GEL 3.8 billion in 4Q24; listed/observable portfolio value up 23.2%, private portfolio value down 0.4%.

  • Recurring dividend income in FY24 was GEL 179.2 million, with a solid outlook for 2025 (180+ GEL million expected).

  • Net income for FY24 was GEL 350.3 million, down 43.1% year-over-year due to lower fair value changes and investment returns.

  • Cash and liquid funds surged to GEL 278.2 million at year-end, up 2.6x year-over-year, mainly from the beer business sale.

  • Buybacks contributed 1 percentage point to NAV growth in the quarter.

Outlook and guidance

  • GEL 300 million capital return programme ongoing through 2026, with GEL 159 million already repurchased and at least GEL 118 million remaining for future buybacks and dividends.

  • Management expects continued NAV per share growth, supported by resilient portfolio performance and a robust Georgian economy.

  • Targeting at least $50 million in debt reduction in 2025, with further share buybacks planned.

  • Double-digit EBITDA growth anticipated in retail pharmacy and hospitals, with hospitals expected to grow EBITDA by 15–20% or more.

  • Economic growth in Georgia is expected to moderate in 2025 amid regional uncertainties, but fundamentals remain strong.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more